NCT00029835已完成3 期
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multi-Center Study of Weight-Reducing Effect and Safety in Obese Patients With Untreated Dyslipidemias
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Sanofi
- 入组人数
- 1,033
- 试验地点
- 60
- 主要终点
- Change from baseline in body weight at 1 year.
研究概览
简要总结
To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with untreated dyslipidemia
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Change from baseline in body weight at 1 year.
次要结局
- Metabolic parameters
研究者
研究点 (60)
Loading locations...
相似试验
已完成
3 期
Obese Patients With Type 2 DiabetesDiabetes Mellitus, Non-Insulin-DependentObesity in DiabetesObesityNCT00029848Sanofi1,045
已完成
3 期
Obese Patients With or Without Comorbidities (RIO-North America)Weight LossObesityNCT00029861Sanofi3,045
已完成
4 期
Phase IV Study of Qsymia in Obese PatientsObesityNCT05378503Alvogen Korea232
已完成
4 期
Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight SubjectsWeight LossNCT04375696Certmedica International GmbH150
已完成
不适用
Study to Evaluate the Effects of a Weight Management Program on Body WeightBody WeightNCT04107155Supplement Formulators, Inc.54